UK - GlaxoSmithKline has officially "postponed" a proposal to increase the value of its chief executive remuneration package by £7.5m.
The decision was taken after discussions with shareholders opposed to long-term incentive awards for Jean-Pierre Garnier. A statement from the pharmaceutical giant said: “After taking account of...
To continue reading this article...
Join Professional Pensions
- Unlimited access to real-time news, analysis and opinion from the industry
- Receive our in-depth monthly magazine in either print or digital format
- Access our Sustainable Investment Hub covering news and opinion from thought leaders in the ESG space
- Receive important and breaking news stories selected by the Editors in our daily newsletter
- Hear from industry experts and other forward-thinking leaders
- Receive a monthly members-only newsletter with exclusive opinion pieces from leading industry experts and a feature from the magazine in advance of its release date